search
Back to results

Innovative Central Line Securement Device in the Pediatric Population

Primary Purpose

Central Line Complication, Central Line Infection, Central Line-Associated Infection

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Wearable Central Line Securement Device (Vest)
Traditional Securement Dressing
Sponsored by
Ryan St. Pierre-Hetz
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Central Line Complication

Eligibility Criteria

0 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with a central line ages 0-18 years old who have never worn a wearable central line securement device (vest) will be eligible for the study.

Exclusion Criteria:

  • Those children who currently wear a central line securement device (vest)
  • Children with central lines who are 19 years or older
  • Those females with central lines and Tanner 2 breast or greater breast development as a wearable central line securement device (vest) will not fit properly to secure the central line and may increase the risk of the central line complications.
  • If the patient does develop breast during the time of the study then the patient will no longer wear the wrap and will go back to securing their device in the traditional way. The investgators will still collect data on that patient and they will be evaluated in the device arm consistent with the intention to treat principle.

Sites / Locations

  • UPMC Children's Hospital of Pittsburgh

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Device

Traditional Securement Dressing

Arm Description

Those in the device arm will be given two wearable central line securement devices and the investigators will encourage continuous wear throughout the duration of the study.

Those is the non-device arm will continue to wear a traditional central line securement dressing as is the standard of care.

Outcomes

Primary Outcome Measures

Primary Outcome - Line Breaks
Number of line breaks
Primary Outcome - Line Dislodgment
Number of line dislodgments
Primary Outcome - Line Infections
Number of and line infections

Secondary Outcome Measures

Change from baseline in parental stress at 3 months
Changes to the mean of parental stress measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in parental stress at 6 months
Changes to the mean of parental stress measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in parental stress at 9 months
Changes to the mean of parental stress measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in parental stress at 12 months
Changes to the mean of parental stress measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in child activity level at 3 months
Changes to the mean of child activity level measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in child activity level at 6 months
Changes to the mean of child activity level measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in child activity level at 9 months
Changes to the mean of child activity level measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in child activity level at 12 months
Changes to the mean of child activity level measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in sleep at 3 months
Changes to the mean of sleep measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in sleep at 6 months
Changes to the mean of sleep measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in sleep at 9 months
Changes to the mean of sleep measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in sleep at 12 months
Changes to the mean of sleep measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in school at 3 months
Changes to the mean of school measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in school at 6 months
Changes to the mean of school measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in school at 9 months
Changes to the mean of school measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in school at 12 months
Changes to the mean of school measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in extracurricular activities at 3 months
Changes to the mean of extracurricular activities measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in extracurricular activities at 6 months
Changes to the mean of extracurricular activities measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in extracurricular activities at 9 months
Changes to the mean of extracurricular activities measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in extracurricular activities at 12 months
Changes to the mean of extracurricular activities measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in family travel at 3 months
Changes to the mean of family travel measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in family travel at 6 months
Changes to the mean of family travel measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in family travel at 9 months
Changes to the mean of family travel measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Change from baseline in family travel at 12 months
Changes to the mean of family travel measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.

Full Information

First Posted
August 17, 2020
Last Updated
September 12, 2022
Sponsor
Ryan St. Pierre-Hetz
search

1. Study Identification

Unique Protocol Identification Number
NCT04522778
Brief Title
Innovative Central Line Securement Device in the Pediatric Population
Official Title
Innovative Central Line Securement Device: Line Complications and Quality of Life in the Pediatric Population as Compared to Traditional Securement Device
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
November 5, 2020 (Actual)
Primary Completion Date
April 2023 (Anticipated)
Study Completion Date
July 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Ryan St. Pierre-Hetz

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study involves evaluating pediatric patients with central lines to determine differences in line complications and quality of life in those with a novel central line securement device (wrap) as compared to those who use a traditional securement device (dressing).
Detailed Description
Children with central lines experience line breaks, line dislodgment's and line infections as a result of traditional securement techniques (dressings). These issues lead to the patients' increased health care utilization and possibly to restriction of movement and delayed development as the children are restricted in their home environment. The purpose of this study is to determine if a wearable central line securement device, can decrease the number of line breaks, line dislodgment and line infections as compared to traditional securement techniques. The hypothesis is that the use of this wearable central line securement device can reduce line breaks, line dislodgment and line infections as compared to the traditional adhesive dressing. A secondary outcome for evaluation will be quality of life. Children are naturally active, however their activity is restricted by the parents given the delicate nature of their line. This study looks to see if quality of life can be improved a more secure wearable attachment device, as compared to traditional securement techniques.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Central Line Complication, Central Line Infection, Central Line-Associated Infection, Central Line Sepsis, Short Gut Syndrome, Quality of Life, Pediatric Disorder

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients with central lines ages 0-18 years old who have never worn a wearable central line securement device (vest) will be eligible for the study. Half of the participants will be randomized to the device arm while the other half of participants will be randomized to the non-device arm. They will be block randomized based on age upon enrollment. Those in the device arm will be given two wearable central line securement devices and the investigators will encourage continuous wear. The study will follow participants prospectively for approximately one year (2020 - 2021).
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Device
Arm Type
Experimental
Arm Description
Those in the device arm will be given two wearable central line securement devices and the investigators will encourage continuous wear throughout the duration of the study.
Arm Title
Traditional Securement Dressing
Arm Type
Active Comparator
Arm Description
Those is the non-device arm will continue to wear a traditional central line securement dressing as is the standard of care.
Intervention Type
Device
Intervention Name(s)
Wearable Central Line Securement Device (Vest)
Intervention Description
The wearable central line securement device is a vest that has attachments for the central line to safely be secured to the body whether it is being used for infusion or unhooked. It also has a front flap, which protects the line from snagging on external objects.
Intervention Type
Other
Intervention Name(s)
Traditional Securement Dressing
Intervention Description
This is a adhesive patch that is traditionally used to secure the external portion of a central line.
Primary Outcome Measure Information:
Title
Primary Outcome - Line Breaks
Description
Number of line breaks
Time Frame
For a maximum of 1 year from enrollment
Title
Primary Outcome - Line Dislodgment
Description
Number of line dislodgments
Time Frame
For a maximum of 1 year from enrollment
Title
Primary Outcome - Line Infections
Description
Number of and line infections
Time Frame
For a maximum of 1 year from enrollment
Secondary Outcome Measure Information:
Title
Change from baseline in parental stress at 3 months
Description
Changes to the mean of parental stress measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs.3months
Title
Change from baseline in parental stress at 6 months
Description
Changes to the mean of parental stress measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 6 months
Title
Change from baseline in parental stress at 9 months
Description
Changes to the mean of parental stress measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 9 months
Title
Change from baseline in parental stress at 12 months
Description
Changes to the mean of parental stress measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 12 months
Title
Change from baseline in child activity level at 3 months
Description
Changes to the mean of child activity level measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 3 months
Title
Change from baseline in child activity level at 6 months
Description
Changes to the mean of child activity level measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 6 months
Title
Change from baseline in child activity level at 9 months
Description
Changes to the mean of child activity level measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs.9 months
Title
Change from baseline in child activity level at 12 months
Description
Changes to the mean of child activity level measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs.12 months
Title
Change from baseline in sleep at 3 months
Description
Changes to the mean of sleep measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 3 months
Title
Change from baseline in sleep at 6 months
Description
Changes to the mean of sleep measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 6 months
Title
Change from baseline in sleep at 9 months
Description
Changes to the mean of sleep measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 9 months
Title
Change from baseline in sleep at 12 months
Description
Changes to the mean of sleep measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 12 months
Title
Change from baseline in school at 3 months
Description
Changes to the mean of school measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 3 months
Title
Change from baseline in school at 6 months
Description
Changes to the mean of school measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 6 months
Title
Change from baseline in school at 9 months
Description
Changes to the mean of school measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 9 months
Title
Change from baseline in school at 12 months
Description
Changes to the mean of school measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 12 months
Title
Change from baseline in extracurricular activities at 3 months
Description
Changes to the mean of extracurricular activities measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 3 months
Title
Change from baseline in extracurricular activities at 6 months
Description
Changes to the mean of extracurricular activities measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs.6 months
Title
Change from baseline in extracurricular activities at 9 months
Description
Changes to the mean of extracurricular activities measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 9 months
Title
Change from baseline in extracurricular activities at 12 months
Description
Changes to the mean of extracurricular activities measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 12 months
Title
Change from baseline in family travel at 3 months
Description
Changes to the mean of family travel measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 3 months
Title
Change from baseline in family travel at 6 months
Description
Changes to the mean of family travel measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 6 months
Title
Change from baseline in family travel at 9 months
Description
Changes to the mean of family travel measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 9 months
Title
Change from baseline in family travel at 12 months
Description
Changes to the mean of family travel measured by a 4 category Likert Scale through a modified Baxter Scale Quality of Life (QOL) questionnaire.
Time Frame
Baseline vs. 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
0 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with a central line ages 0-18 years old who have never worn a wearable central line securement device (vest) will be eligible for the study. Exclusion Criteria: Those children who currently wear a central line securement device (vest) Children with central lines who are 19 years or older Those females with central lines and Tanner 2 breast or greater breast development as a wearable central line securement device (vest) will not fit properly to secure the central line and may increase the risk of the central line complications. If the patient does develop breast during the time of the study then the patient will no longer wear the wrap and will go back to securing their device in the traditional way. The investgators will still collect data on that patient and they will be evaluated in the device arm consistent with the intention to treat principle.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Angelica Mazzarini, MD
Organizational Affiliation
UPMC Children's Hospital of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
UPMC Children's Hospital of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15224
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
18341949
Citation
Hwang FR, Stavropoulos SW, Shlansky-Goldberg RD, Mondschein JI, Patel AA, Solomon JA, Itkin M, Soulen MC, Chittams JL, Trerotola SO. Tunneled infusion catheter breakage: frequency and repair kit outcomes. J Vasc Interv Radiol. 2008 Feb;19(2 Pt 1):201-6. doi: 10.1016/j.jvir.2007.08.030.
Results Reference
background
PubMed Identifier
22146741
Citation
Lundgren IS, Zhou C, Malone FR, McAfee NG, Gantt S, Zerr DM. Central venous catheter repair is associated with an increased risk of bacteremia and central line-associated bloodstream infection in pediatric patients. Pediatr Infect Dis J. 2012 Apr;31(4):337-40. doi: 10.1097/INF.0b013e31823eeec5.
Results Reference
background
PubMed Identifier
15064868
Citation
Cesaro S, Corro R, Pelosin A, Gamba P, Zadra N, Fusaro F, Pillon M, Cusinato R, Zampieri C, Magagna L, Cavaliere M, Tridello G, Zanon G, Zanesco L. A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol. 2004 Mar;83(3):183-8. doi: 10.1007/s00277-003-0796-9. Epub 2003 Nov 13.
Results Reference
background
PubMed Identifier
26459655
Citation
Ullman AJ, Marsh N, Mihala G, Cooke M, Rickard CM. Complications of Central Venous Access Devices: A Systematic Review. Pediatrics. 2015 Nov;136(5):e1331-44. doi: 10.1542/peds.2015-1507. Epub 2015 Oct 12.
Results Reference
background
PubMed Identifier
21398316
Citation
Peng C, Monagle P, Newall F. Clinical outcomes of management of CVAD occlusions. Arch Dis Child. 2011 Sep;96(9):885-7. doi: 10.1136/adc.2010.194969. Epub 2011 Mar 11.
Results Reference
background
PubMed Identifier
19529913
Citation
Rey C, Alvarez F, De La Rua V, Medina A, Concha A, Diaz JJ, Menendez S, Los Arcos M, Mayordomo-Colunga J. Mechanical complications during central venous cannulations in pediatric patients. Intensive Care Med. 2009 Aug;35(8):1438-43. doi: 10.1007/s00134-009-1534-0. Epub 2009 Jun 16.
Results Reference
background
PubMed Identifier
25972431
Citation
Winkler MF, DiMaria-Ghalili RA, Guenter P, Resnick HE, Robinson L, Lyman B, Ireton-Jones C, Banchik LH, Steiger E. Characteristics of a Cohort of Home Parenteral Nutrition Patients at the Time of Enrollment in the Sustain Registry. JPEN J Parenter Enteral Nutr. 2016 Nov;40(8):1140-1149. doi: 10.1177/0148607115586575. Epub 2015 May 13.
Results Reference
background
PubMed Identifier
14613562
Citation
Burckhardt CS, Anderson KL. The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes. 2003 Oct 23;1:60. doi: 10.1186/1477-7525-1-60.
Results Reference
background
PubMed Identifier
26022965
Citation
Gimeno-Santos E, Raste Y, Demeyer H, Louvaris Z, de Jong C, Rabinovich RA, Hopkinson NS, Polkey MI, Vogiatzis I, Tabberer M, Dobbels F, Ivanoff N, de Boer WI, van der Molen T, Kulich K, Serra I, Basagana X, Troosters T, Puhan MA, Karlsson N, Garcia-Aymerich J; PROactive consortium. The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease. Eur Respir J. 2015 Oct;46(4):988-1000. doi: 10.1183/09031936.00183014. Epub 2015 May 28.
Results Reference
background

Learn more about this trial

Innovative Central Line Securement Device in the Pediatric Population

We'll reach out to this number within 24 hrs